The estimated Net Worth of Emil D Kakkis is at least $318,941,542.90. Emil D Kakkis owns over 2,329,741 units of Ultragenyx Pharmaceutical, Inc. stock worth over $318,941,542.90.
| Transaction Date | Company | Shares | Type | Owned | Price | Value | Post Value |
|---|---|---|---|---|---|---|---|
| 4th January 2021 | RARE - Ultragenyx Pharmaceutical, Inc. | 30,000 | Open or private sale | 2,329,741 | $136.90 | $4,107,000.00 | $318,941,542.90 |
| 2nd November 2020 | RARE - Ultragenyx Pharmaceutical, Inc. | 30,000 | Open or private sale | 2,359,741 | $96.82 | $2,904,600.00 | $228,470,123.62 |
| 14th October 2020 | RARE - Ultragenyx Pharmaceutical, Inc. | 852 | Payment by withholding | 610,189 | $92.69 | $78,971.88 | $56,558,418.41 |
| 1st March 2019 | RARE - Ultragenyx Pharmaceutical, Inc. | 2,802 | Payment by withholding | 467,670 | $67.55 | $189,275.10 | $31,591,108.50 |
| 1st March 2019 | RARE - Ultragenyx Pharmaceutical, Inc. | 20,000 | Grant/award etc. | 470,472 | $0.00 | ||
| 19th April 2019 | RARE - Ultragenyx Pharmaceutical, Inc. | 798 | Payment by withholding | 466,785 | $64.43 | $51,415.14 | $30,074,957.55 |
| 6th May 2019 | RARE - Ultragenyx Pharmaceutical, Inc. | 3,435 | Grant/award etc. | 470,220 | $0.00 | ||
| 21st May 2019 | RARE - Ultragenyx Pharmaceutical, Inc. | 1,414 | Payment by withholding | 468,806 | $59.50 | $84,133.00 | $27,893,957.00 |
| 1st June 2019 | RARE - Ultragenyx Pharmaceutical, Inc. | 1,327 | Payment by withholding | 467,479 | $54.93 | $72,892.11 | $25,678,621.47 |
| 11th September 2019 | RARE - Ultragenyx Pharmaceutical, Inc. | 5,000 | Open or private purchase | 472,479 | $43.63 | $218,150.00 | $20,614,258.77 |
| 14th October 2019 | RARE - Ultragenyx Pharmaceutical, Inc. | 3,435 | Grant/award etc. | 475,914 | $0.00 | ||
| 1st March 2020 | RARE - Ultragenyx Pharmaceutical, Inc. | 6,896 | Payment by withholding | 504,800 | $56.08 | $386,727.68 | $28,309,184.00 |
| 1st March 2020 | RARE - Ultragenyx Pharmaceutical, Inc. | 18,782 | Grant/award etc. | 511,696 | $0.00 | ||
| 1st March 2020 | RARE - Ultragenyx Pharmaceutical, Inc. | 17,000 | Grant/award etc. | 492,914 | $0.00 | ||
| 12th March 2020 | RARE - Ultragenyx Pharmaceutical, Inc. | 66,533 | Exercise of in-the-money or at-the-money derivatives securities (usually options) | 654,500 | $3.01 | $199,998.20 | $1,967,427.00 |
| 12th March 2020 | RARE - Ultragenyx Pharmaceutical, Inc. | 83,167 | Exercise of in-the-money or at-the-money derivatives securities (usually options) | 587,967 | $3.01 | $250,000.00 | $1,767,428.80 |
| 19th April 2020 | RARE - Ultragenyx Pharmaceutical, Inc. | 851 | Payment by withholding | 653,649 | $58.57 | $49,843.07 | $38,284,221.93 |
| 6th May 2020 | RARE - Ultragenyx Pharmaceutical, Inc. | 852 | Payment by withholding | 652,797 | $66.26 | $56,453.52 | $43,254,329.22 |
| 1st June 2020 | RARE - Ultragenyx Pharmaceutical, Inc. | 1,334 | Payment by withholding | 611,041 | $69.38 | $92,552.92 | $42,394,024.58 |
| 13th July 2020 | RARE - Ultragenyx Pharmaceutical, Inc. | 40,000 | Open or private sale | 2,419,741 | $85.35 | $3,414,000.00 | $206,524,894.35 |
| 1st September 2020 | RARE - Ultragenyx Pharmaceutical, Inc. | 30,000 | Open or private sale | 2,389,741 | $82.63 | $2,478,900.00 | $197,464,298.83 |